Table 2.
Service | Human-contact MRSA/samples collected | Animal-contact MRSA/samples collected | Total contact MRSA/samples collected |
---|---|---|---|
Community practicea | 6/37 (16.2%) | 7/24 (29.2%) | 13/61 (21.3%) |
Dermatologyb | 1/86 (1.2%) | 8/48 (16.7%) | 9/134 (6.7%) |
Intensive Care Unitc | 8/48 (16.7%) | 5/49 (10.2%) | 13/97 (13.4%) |
Surgeryd | 19/108 (17.6%) | 8/135 (5.9%) | 27/243 (11.1%) |
Generale | N/A | 15/34 (44.1%) | 15/34 (44.1%) |
Total | 34/279 (12.2%) | 43/290 (14.8%) | 77/569 (13.5%) |
Included examination and treatment area of the service.
Included treatment area and ward of the service.
Included treatment area of the service.
Included pre-surgery, surgery rooms and wards of the service.
Included the carts that transport patients from service to service; since they do not belong to one specific service.
MRSA, methicillin-resistant Staphylococcus aureus.